Compile Data Set for Download or QSAR
maximum 50k data
Found 192 of ph data with Target = 'Somatostatin receptor type 5'
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144757(US8952128, 15)
Affinity DataKi:  0.0800nM ΔG°:  -57.6kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144752(US8952128, 11)
Affinity DataKi:  0.0900nM ΔG°:  -57.3kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144751(US8952128, 10)
Affinity DataKi:  0.160nM ΔG°:  -55.9kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144755(US8952128, 13)
Affinity DataKi:  0.230nM ΔG°:  -55.0kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144761(US8952128, 20)
Affinity DataKi:  0.330nM ΔG°:  -54.1kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144756(US8952128, 14)
Affinity DataKi:  0.360nM ΔG°:  -53.9kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144748(US8952128, 7)
Affinity DataKi:  0.510nM ΔG°:  -53.0kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144742(US8952128, 6)
Affinity DataKi:  0.520nM ΔG°:  -53.0kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144768(US8952128, 27)
Affinity DataKi:  0.530nM ΔG°:  -52.9kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144753(US8952128, 12 | US8952128, 46)
Affinity DataKi:  0.740nM ΔG°:  -52.1kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144776(US8952128, 33)
Affinity DataKi:  0.820nM ΔG°:  -51.9kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144759(US8952128, 17)
Affinity DataKi:  0.860nM ΔG°:  -51.7kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144740(US8952128, 4)
Affinity DataKi:  0.920nM ΔG°:  -51.6kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144766(US8952128, 25)
Affinity DataKi:  0.950nM ΔG°:  -51.5kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144786(US8952128, 44)
Affinity DataKi:  1.38nM ΔG°:  -50.6kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144749(US8952128, 8)
Affinity DataKi:  1.49nM ΔG°:  -50.4kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144750(US8952128, 9)
Affinity DataKi:  1.54nM ΔG°:  -50.3kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144773(US8952128, 30 | US8952128, 32)
Affinity DataKi:  1.58nM ΔG°:  -50.2kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144741(US8952128, 5)
Affinity DataKi:  1.65nM ΔG°:  -50.1kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144771(US8952128, 29)
Affinity DataKi:  2.37nM ΔG°:  -49.2kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144765(US8952128, 24)
Affinity DataKi:  2.39nM ΔG°:  -49.2kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144779(US8952128, 37)
Affinity DataKi:  2.45nM ΔG°:  -49.1kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123235(US8742110, 3-20)
Affinity DataIC50:  0.129nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123247(US8742110, 4-11)
Affinity DataIC50:  0.152nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123253(US8742110, 4-17)
Affinity DataIC50:  0.165nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123270(US8742110, 5-6)
Affinity DataIC50:  0.172nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123248(US8742110, 4-12)
Affinity DataIC50:  0.188nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123300(US8742110, 6-18)
Affinity DataIC50:  0.225nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123254(US8742110, 4-18)
Affinity DataIC50:  0.228nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123271(US8742110, 5-7)
Affinity DataIC50:  0.233nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123255(US8742110, 4-19)
Affinity DataIC50:  0.243nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123296(US8742110, 6-14)
Affinity DataIC50:  0.260nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123252(US8742110, 4-16)
Affinity DataIC50:  0.272nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123277(US8742110, 5-13)
Affinity DataIC50:  0.317nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123227(US8742110, 3-12)
Affinity DataIC50:  0.323nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123306(US8742110, 6-24)
Affinity DataIC50:  0.342nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123234(US8742110, 3-19)
Affinity DataIC50:  0.359nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123264(US8742110, 4-28)
Affinity DataIC50:  0.395nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123257(US8742110, 4-21)
Affinity DataIC50:  0.397nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123250(US8742110, 4-14)
Affinity DataIC50:  0.407nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123243(US8742110, 4-7)
Affinity DataIC50:  0.409nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123179(US8742110, 1-28)
Affinity DataIC50:  0.421nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123272(US8742110, 5-8)
Affinity DataIC50:  0.424nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123236(US8742110, 3-21)
Affinity DataIC50:  0.437nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123245(US8742110, 4-9)
Affinity DataIC50:  0.439nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123258(US8742110, 4-22)
Affinity DataIC50:  0.468nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123244(US8742110, 4-8)
Affinity DataIC50:  0.474nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123239(US8742110, 4-3)
Affinity DataIC50:  0.490nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123240(US8742110, 4-4)
Affinity DataIC50:  0.502nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM123242(US8742110, 4-6)
Affinity DataIC50:  0.546nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 192 total ) | Next | Last >>
Jump to: